GLP-1 and incretin
What the record holds about the schedule: how often each of these is given, what its half-life is, and whether anything accumulates between doses.
14 compounds, 12 with a half-life, 9 curves drawn
label trial circulated
4 classes · 41 compounds
Protocols
How each class is actually run, with the origin of every schedule printed beside it. A label, a trial, a circulated figure and an animal extrapolation are not the same kind of fact.
Last updated
The chip beside the dose is the page
Four kinds of thing get printed as a peptide dose: an approved product label, a trial protocol, a figure the community circulates, and arithmetic somebody did on an animal study. Everywhere else they appear in identical type. Here each schedule carries the one that applies, and the four are defined.
Growth hormone axis
What the record holds about the schedule for the GH secretagogues and the hormone itself: the interval, the half-life, and whether anything accumulates.
15 compounds, 12 with a half-life, 11 curves drawn
label trial circulated
Tissue repair
What the record holds about the schedule for the classic repair stack: the interval, the half-life, and what the half-lives on file imply about it.
7 compounds, 4 with a half-life, 4 curves drawn
label trial circulated
Mitochondrial
What the record holds about the schedule for the mitochondrial peptides — which is a schedule for each of them and a half-life for none.
5 compounds, 0 with a half-life, no curve drawn
trial circulated extrapolated
Before reading a curve
- What a protocol is — the four source classes, the accumulation arithmetic, and what a curve here does not model
- Protocol builder — turn a list of compounds into a week of administration days
- Stack checker — nine dimensions across every pairing, including the pairings with nothing on record
The classes that are not here
The melanocortins, the nootropic peptides, the thymic peptides and the cosmetic actives are not on this hub yet. Each needs the same columns as the four above, and for most of them the half-life column would be empty end to end — which is worth publishing, but as a page that says so deliberately rather than one that looks unfinished. The mitochondrial page is the shape those will take.